Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese
Low-dose rituximab improves progression in early-stage medium-to-high-risk membranous nephropathy: an exploratory study
XU Qiuyu, AI Sanxi, WANG Gangan, JIA Chunyu, WANG Jiahui, ZHENG Ke, QIN Yan, CHEN Gang, LI Xuemei
Chinese Journal of Clinical Pharmacology and Therapeutics . 2024, (7): 744 -751 .  DOI: 10.12092/j.issn.1009-2501.2024.07.003